中国心理卫生杂志2026,Vol.40Issue(11):961-969,9.DOI:10.3969/j.issn.1000-6729.2026.11.04
正念认知疗法联合药物治疗轻中度抑郁障碍的随机对照试验
A randomized controlled trial of mindfulness-based cognitive therapy as an adjunct to pharmacotherapy for mild to moderate depressive disorder
摘要
Abstract
Objective:To examine the effects of mindfulness-based cognitive therapy(MBCT)as an adjunct to pharmacotherapy on defense mechanisms and clinical outcomes in patients with mild to moderate depressive dis-order.Methods:In a single-center randomized controlled trial,149 patients with mild to moderate depressive disor-der were assigned to an MBCT group or a health education group to receive 8 weeks of the respective intervention in addition to standard pharmacotherapy.Mindfulness,defense mechanisms,Hamilton Depression Rating Scale(HAMD)scores and Hamilton Anxiety Rating Scale(HAMA)scores were assessed at baseline and at weeks 2,4 and 8,and data were analyzed according to the intention-to-treat principle using generalized linear models.Results:Across both groups,scores on all mindfulness facets and mature defenses increased over time,whereas immature and intermediate defenses and HAMD/HAMA scores decreased(all time effects P<0.05).Overall,the MBCT group showed higher scores across all mindfulness dimensions and mature defenses,lower scores on intermediate defenses and HAMD than the control group,and a higher overall response rate at week 8(P<0.05).Generalized linear models indicated an additional therapeutic advantage of MBCT at week 8.Conclusion:MBCT,as an adjunct to pharmacotherapy,can improve mindfulness and defensive functioning and further alleviate depressive and anxiety symptoms in patients with mild to moderate depressive disorder within 8 weeks.关键词
正念认知疗法/抑郁障碍/防御方式/焦虑/治疗效果Key words
mindfulness-based cognitive therapy/depressive disorder/defense mechanisms/anxiety/thera-peutic effect分类
医药卫生引用本文复制引用
何清清,胡静,何淑玲,龙洁,胡龙,郝雪宇,李宜,曾婷燕,刘慕云..正念认知疗法联合药物治疗轻中度抑郁障碍的随机对照试验[J].中国心理卫生杂志,2026,40(11):961-969,9.基金项目
广东省医学科学技术研究基金项目(B2024336) (B2024336)